Rare diseases
Investigational molecules
Locations
Back to Poland17 clinical trials in Wołomin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals
PolandStudy of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
PolandEfficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma
PolandA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
PolandStudy of Actisoufre nasal spray containing sodium sulfide and saccharomyces extract for adults and children over 6 years with acute rhinitis, rhinopharyngitis, and rhinosinusitis
PolandEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PolandA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
PolandStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
PolandStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
PolandStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
PolandThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on Sjögren's Disease treatments, investigating novel therapies including sibeprenlimab, dazodalibep, and efgartigimod. Research aims to evaluate systemic disease activity and improve treatment outcomes.
Comprehensive evaluation of long-term safety and efficacy in treating systemic manifestations.
Advancing treatments for Psoriatic Arthritis and Axial Spondyloarthritis, with studies examining multiple therapeutic agents including sonelokimab, deucravacitinib, and tofacitinib.
Focus on both treatment-naïve patients and those with inadequate response to previous therapies.
Research encompassing influenza treatment and allergic conditions, including investigations of baloxavir marboxil and innovative treatments for birch pollen allergies.
Studies include both therapeutic and preventive approaches for respiratory conditions.
Diverse research portfolio including studies on electronic cigarette cessation and chronic kidney disease-associated conditions.
Investigating novel approaches to address modern health challenges and chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
